A Multimodal Feature Fusion Model for Predicting Secondary Loss of Response After Infliximab Treatment in Crohn's Disease Patients: A Multicenter Study
Digestive Endoscopy · 2026-01 · 38 (1)
DOI: 10.1111/den.70097 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive Endoscopy, online erschienen am 07.01.2026. Verfasst von Chang Rong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China. Hauptthemen laut MEDLINE: Crohn Disease, Infliximab, Gastrointestinal Agents, Deep Learning. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Research Fund of Anhui Institute of Transitional Medicine, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
Background
The early prediction of secondary loss of response (SLOR) after infliximab (IFX) treatment in Crohn's disease (CD) patients can help optimize treatment strategies. This study developed and validated a multimodal deep learning model that uses baseline endoscopic ulcer lesions to predict SLOR. Additionally, a deep learning–based ulcer detection model was established to automatically identify ulcer lesions.
Methods
A total of 385 CD patients from three centers were retrospectively analyzed. An ulcer detection model was developed to identify endoscopic ulcer lesions from 12,092 endoscopic images. Following lesion localization, 2189 ulcer images were selected and used to train feature fusion models, while clinical data were incorporated to construct a multimodal model for SLOR prediction. These models were validated in two external test cohorts.
Results
The ulcer detection model achieved precision values of 0.853 in the validation cohort. The multimodal model outperformed the clinical model in predicting SLOR with areas under the ROC curve (AUCs) of 0.892, 0.847, and 0.824 in the internal validation cohort, external test cohort 1, and external test cohort 2, respectively. Gradient‐weighted class activation mapping (Grad‐CAMs) revealed highly pronounced activation of the ulcerated area in SLOR patients in the model, providing crucial support for model prediction.
Conclusions
The ulcer detection model effectively identifies ulcer lesions, increasing diagnostic efficiency. The multimodal model, which integrates baseline endoscopic images and clinical data, offers a potential tool for early SLOR prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
- Division of Life and Medicine, School of Biomedical Engineering, University of Science and Technology of China, Hefei, People's Republic of China.
- Suzhou Institute for Advanced Research, University of Science and Technology of China, Suzhou, People's Republic of China.
- Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
- Division of Life Sciences and Medicine, Department of Interventional Radiology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, People's Republic of China.
Förderung
- Research Fund of Anhui Institute of Transitional Medicine
- Natural Science Foundation of Anhui Province
Zitieren
APA
Rong, C., Liu, Y., Hu, J., Cheng, T., Tai, Z., Li, S., Shen, Y., Zhang, B., Gao, Y., Zheng, X., Liu, K., Sun, M., & Wu, X. (2026). A Multimodal Feature Fusion Model for Predicting Secondary Loss of Response After Infliximab Treatment in Crohn's Disease Patients: A Multicenter Study. Digestive Endoscopy, 38(1). https://doi.org/10.1111/den.70097
Vancouver
Rong C, Liu Y, Hu J, Cheng T, Tai Z, Li S, et al. A Multimodal Feature Fusion Model for Predicting Secondary Loss of Response After Infliximab Treatment in Crohn's Disease Patients: A Multicenter Study. Digestive Endoscopy. 2026;38(1). doi:10.1111/den.70097
BibTeX
@article{Rong2026,
author = {Rong, Chang and Liu, Yulong and Hu, Jing and Cheng, Ting and Tai, Zhipeng and Li, Shuai and Shen, Yi and Zhang, Bo and Gao, Yankun and Zheng, Xiaoming and Liu, Kaicai and Sun, Mingzhai and Wu, Xingwang},
title = {A Multimodal Feature Fusion Model for Predicting Secondary Loss of Response After Infliximab Treatment in Crohn's Disease Patients: A Multicenter Study},
journal = {Digestive Endoscopy},
year = {2026},
volume = {38},
number = {1},
doi = {10.1111/den.70097}
}
EUVIMED